Pharmacology News

In this video, Joel M. Gelfand, MD, MSCE, professor of dermatology and epidemiology at the University of Pennsylvania Perelman School of Medicine, spoke with Healio about research on deucravacitinib presented at AAD VMX 2021.

Higher blood levels of eicosapentaenoic acid 1 year after daily omega-3 carboxylic acid supplementation were not associated with lower CV risk, according to a secondary analysis of the STRENGTH trial.

Among patients with atherosclerotic CVD, there was no difference in CV events or major bleeding according to aspirin dose, researchers reported at the American College of Cardiology Scientific Session.

Daily probiotic use correlated with a reduction in upper respiratory tract infection symptoms among overweigh individuals, according to a presentation at the Digestive Disease Week media briefing.

Chronic pain is a complex condition that requires integrative care, which can include proper medication use, cognitive behavioral therapy, mindfulness and physical therapy, according to a speaker at the ACP Internal Medicine Meeting.

A hospital intervention designed to raise awareness of naloxone and remove prescribing barriers was associated with a 584% increase in prescriptions among patients at high risk for an opioid overdose, according to recent research.

In a retrospective cohort study, non-English speaking patients received fewer pain assessments and fewer doses of NSAIDs and oxycodone therapeutic equivalents after a cesarean delivery, according to researchers.

Omega-3 fatty acid supplementation was associated with elevated risk for atrial fibrillation among patients with elevated triglyceride levels at high CV risk, researchers reported.

In an update to the 2017 hypertension guideline, the American Heart Association recommended lifestyle changes for patients with slightly elevated BP, adding medication if necessary after 6 months.

There are 2 to 3 million people with type 1 diabetes in the United States, and about half of them are managed by general internists, according to Guillermo E. Umpierrez, MD, MACP, president-elect of the American Diabetes Association.